Live Quote · NASDAQVRTXHealthcare· Biotechnology

Vertex Pharmaceuticals Incorporated

$515.02▼ 1.08%($-5.64)
MKT CAP $130.58BNEXT EARNINGS Feb 11, 2027
50%
Bullish
TickerSpark Score
78/100
▌ Solid
53
Valuation
100
Profitability
80
Growth
96
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRTX research report →

Analyst Price Target
$579.29+12.5% vs. today

Range $350 – $665

Analyst RatingBuy
49 Buy6 Hold1 Sell

Price Chart

+21.95% · this period
$558.88$490.60$422.32Nov 20May 26Nov 20
52-Week Range66% of range
Low
$412.27
Current
$515.02
High
$568.67

AI analysis · Last refreshed November 17, 2026 · Live quote · Not investment advice